By 2029, 56% of the global 65+ population will be in APAC, a segment often overlooked. Euromonitor's Inclusivity – Empowerment – Indulgence framework helps businesses tap into this market by addressing physical, emotional, and lifestyle needs, as well as cultural dynamics like age discrimination and multigenerational living, unlocking growth and competitive advantage.
Global commodity markets are under pressure in 2025 amid rising trade tensions, US protectionism, and slowing global growth. Energy prices remain subdued, with oil at a 4-year low due to oversupply concerns and weak demand, while a stronger supply outlook for major crops is set to keep downward pressure on food commodity prices. Meanwhile, metals markets remain mixed, as policy-driven volatility curbs price momentum despite prospects for recovery later in the year.
The expansion of BRICS+ marks a pivotal shift in the global economic landscape, offering a strategic response to escalating trade tensions and mounting geopolitical uncertainty. By integrating diverse emerging markets, fostering deeper cooperation and diversifying trade routes, the growing bloc can help to enhance supply chain resilience and mitigate exposure to global risks, while its vibrant consumer base offers vast growth opportunities, fuelled by rising incomes and evolving demand.
In the global retail industry, macroeconomic concerns continue to weigh on consumers, placing a heavy burden on retailers specialising in sales of discretionary goods. Even so, thanks to the skyrocketing popularity of online shopping and the growing affluence of consumers in the Asia Pacific region, global retail sales recorded positive, albeit subdued, growth in 2024. Future growth will be largely dependent on the continued expansion of e-commerce and the remarkable rise of the Asia Pacific retail sector.
The laws and regulations regarding cannabis in Japan have undergone significant changes in recent years. In particular, in 2023, a revised bill was proposed for the Cannabis Control Law, which established a new offence for use and officially approved Epidiolex, a CBD preparation for medical use. The revised law was delayed from the initially scheduled date of October 2024, and then came into effect on 12 December, but expectations for growth in the CBD market temporarily slowed in 2024. This article explains the reasons for this, the current situation, and the outlook for the future market.
With US President Donald Trump’s second term officially beginning from January 2025, momentum is building around significant changes to US trade policy, specifically around higher tariffs and restrictions aimed at reducing the US’s trade deficits.